Bromfenac Sodium-impurities | Pharmaffiliates

bromfenac sodium

The FDA and European approvals for Bromfenac Sodium are for use one day before and two weeks following cataract surgery for the treatment of ocular inflammation and pain. It is a nonsteroidal anti-inflammatory drug.. Reference standards of Bromfenac Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

PA 02 47520

7,7'-Bis(4-bromobenzoyl)-1H,1'H-[3,3']-biindolinylidene-2,2'-dione


  • Catalogue No.:PA 02 47520

  • CAS :

    1798431-98-7

  • Molecular Formula : C30H16Br2N2O4

  • Molecular Weight : 628.28

PA 02 47530

7-(4-Bromobenzoyl)indolin-2-one


  • Catalogue No.:PA 02 47530

  • CAS :

    91713-91-6

  • Molecular Formula : C15H10BrNO2

  • Molecular Weight : 316.15